The Burnham Institute for Medical Research (Burnham) will receive $5,925,878 in grants awarded from the California Institute for Regenerative Medicine (CIRM) as part of the first research grants approved under Proposition 71, the Stem Cell Research and Cures Act, adopted by California voters in November 2004.
The Independent Citizen's Oversight Committee, the governing body charged with implementing Proposition 71, has approved the allocation of $45 million to fund 72 grants awarded under CIRM's Scientific Excellence through Exploration and Development (SEED) Grant Program.
"In funding these SEED grants, CIRM is fulfilling its commitment to making a major impact on stem cell science and health care," said Dr. Evan Snyder, Professor and Director of Stem Cell Research at Burnham.
"These are the first grants to support fundamental science. By giving priority to SEED funding, CIRM is supporting early-stage science that could not be funded under current stem cell funding guidelines at the National Institutes of Health," Snyder continued.
At Burnham, the SEED funding will help launch projects each of which will explore a different aspect of stem cell biology in areas of medical relevance ranging from heart disease, Parkinson's, cancer, and neural development, to the development of methods for deriving and culturing human embryonic stem cell lines.